moxisylyte has been researched along with Syndrome in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritch, R | 1 |
| Wand, M | 1 |
| Bitker, MO | 1 |
| Veaux Renault, V | 1 |
| Pichon, J | 1 |
| Perrigot, M | 1 |
| Chatelain, C | 1 |
2 other studies available for moxisylyte and Syndrome
| Article | Year |
|---|---|
Treatment of the Weill-Marchesani syndrome.
Topics: Abnormalities, Multiple; Ectopia Lentis; Glaucoma; Humans; Lens Subluxation; Lens, Crystalline; Moxi | 1981 |
[The uretheral syndrome in men or prostatodynia].
Topics: Adult; Genital Diseases, Male; Humans; Male; Middle Aged; Moxisylyte; Pain; Prostatic Diseases; Synd | 1988 |